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Abstract
Background: Streptococcus pneumoniae is a widely distributed commensal Gram-positive bacteria of the upper 
respiratory tract. Pneumococcal colonization can progress to invasive disease, and thus become lethal, reason why 
antibiotics and vaccines are designed to limit the dramatic effects of the bacteria in such cases. As a consequence, 
pneumococcus has developed efficient antibiotic resistance, and the use of vaccines covering a limited number of 
serotypes such as Pneumovax® and Prevnar® results in the expansion of non-covered serotypes. Pneumococcal surface 
proteins represent challenging candidates for the development of new therapeutic targets against the bacteria. 
Despite the number of described virulence factors, we believe that the majority of them remain to be characterized. 
This is the reason why pneumococcus invasion processes are still largely unknown.
Results: Availability of genome sequences facilitated the identification of pneumococcal surface proteins bearing 
characteristic motifs such as choline-binding proteins (Cbp) and peptidoglycan binding (LPXTG) proteins. We designed 
a medium throughput approach to systematically test for interactions between these pneumococcal surface proteins 
and host proteins (extracellular matrix proteins, circulating proteins or immunity related proteins). We cloned, 
expressed and purified 28 pneumococcal surface proteins. Interactions were tested in a solid phase assay, which led to 
the identification of 23 protein-protein interactions among which 20 are new.
Conclusions: We conclude that whether peptidoglycan binding proteins do not appear to be major adhesins, most of 
the choline-binding proteins interact with host proteins (elastin and C reactive proteins are the major Cbp partners). 
These newly identified interactions open the way to a better understanding of host-pneumococcal interactions.
Background
Streptococcus pneumoniae is a common bacteria of the
commensal flora and together with other bacterial spe-
cies, colonizes the nasopharyngeal niche and upper respi-
ratory tract. Pneumococcal colonization is mostly
asymptomatic, but can progress to respiratory or even
systemic disease, causing the majority of community-
acquired pneumonia and invasive diseases such as men-
ingitis and bacteremia. Risk groups include young chil-
dren, elderly people and patients with
immunodeficiencies. In USA and Europe the annual inci-
dence of invasive pneumococcal infections ranges from
10 to 100 per 100 000 with a mortality rate of 10 to 50%;
the highest incidence concerns people older than 65 years
[1]. The burden of pneumococcal pneumonia is very high
in developing countries, and estimated to cause every
year the death of more than 1 million children under the
age of five. The current seven-valent conjugate vaccine
for children is effective against pneumococcal invasive
diseases caused by the vaccine-type strains. As more than
90 serotypes have been described, the vaccine coverage is
limited and non-vaccine serotypes replacement is a seri-
ous threat for the near future [2]. The search for new vac-
cine candidates that would elicit protection against a
broader range of pneumococcal strains or for new drugs
to circumvent pneumococcal invasive disease is of tre-
mendous interest.
Over the past 20 years, the importance of proteins for S.
pneumoniae  virulence has become clear. Research has
been stimulated by the observation that pneumococcal
proteins, and more precisely, surface-exposed proteins,
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represent promising candidates for the development of
vaccines that could be common to all pneumococcal
serotypes [3]. Mechanisms and pneumococcal factors
t h a t  e n a b l e  h o s t  e p i t h e l i a l  a n d  t i s s u e  b a r r i e r s  t o  b e
breached during the progression from colonization to
invasive infection are still poorly understood. The role of
the capsular polysaccharides in virulence has long been
studied [4]. In order to better understand the pathogenic
processes of pneumococcus, screens have been con-
ducted, with very diverse methodologies, which allowed
the identification of proteins potentially involved in host-
pathogen interactions [5-9]. It now appears clearly that
cell-surface proteins participate in many stages of the col-
onization process and/or the disease transition.
One of the first identified virulence factor of the pneu-
mococcus is the toxin pneumolysin [10] which is able to
interfere with the immune system [11,12] as well as
directly destabilize host's membranes [13]. Interactions of
PspA and CbpA with lactoferrin and factor H, respec-
tively as well as proteolysis of IgA1 play important roles
in the escape from the innate immune system [14-16].
The pneumococcal glycosidases NanA, NanB and SpnHL
cleave terminal sugars from human glycoconjugates,
which might reveal receptors for bacterial adherence
and/or help for spreading of the bacteria [17]. Contrary to
other pathogenic bacteria, very few interactions of pneu-
mococcal proteins with extracellular matrix components
have been described. One example is the interaction of
PavA with fibronectin [18]. Direct adherence of pneumo-
cocci to epithelial cells was shown to be mediated by cho-
line-binding protein A (CbpA) and PsaA which bind to
polymeric Ig receptor and E-cadherin, respectively [19-
22]. Finally, a way to progress into host tissue is to recruit
the host protease plasmin at the bacterial surface. We
recently demonstrated that the pneumococcal surface-
exposed CbpE is a receptor for the plasminogen (as for
enolase [23] and GAPDH [24]), activation of which into
plasmin facilitates traversal of S. pneumoniae through (i)
a reconstituted basement membrane, and (ii) epithelial
and endothelial cell barriers via a pericellular route
[25,26].
Beside the secreted or membrane-anchored protein
associated with N-terminal peptide signal, three major
groups of pneumococcal cell-surface proteins have been
identified from specific sequence motifs which are related
to three different attachment modes to the cell wall, com-
posed by peptidoglycan, teichoic acids and lipoteichoic
acids. Teichoic and lipoteichoic acids are decorated with
phosphorylcholine (PCho) residues that anchor a group
of proteins, the choline-binding proteins (already men-
t i o n e d  a s  C b p s ) .  T h e s e  p r o t e i n s  h a r b o r  r e p e a t e d
sequences of approximately 20 amino acids, the choline-
binding module, generally present in the C-terminal part
of the protein. Two to twelve modules form the choline-
binding domain is attached to PCho in a non-covalent
manner. Beside the choline-binding domain, the amino-
acid sequences vary greatly and for some Cbps, various
enzymatic activities or binding properties have been
identified. The virulence factors PspA, CbpA, LytA and
CbpE are part of this protein family. Secondly, in Gram-
positive bacteria, proteins can be covalently linked to the
peptide moiety of the peptidoglycan [27]. Transpeptidase
enzymes called sortases catalyze this anchorage on a spe-
cific amino-acid sequence motif: LPXTG. This motif can
vary from the canonical LPXTG sequence, this is the case
for the pilin proteins (RrgA: YPRTG; RrgB: IPQTG; RrgC:
VPDTG). The pneumococcal glycosidases NanA, and
SpnHL are members of this LPXTG proteins family.
Thirdly, cell-surface lipoproteins are covalently linked to
the membrane phospholipids through the N-terminus
LXXC motif recognized by the signal peptidase II. PsaA is
a lipoprotein.
The availability of genomic sequence data for pneumo-
coccal strains has facilitated the identification of addi-
tional pneumococcal surface proteins, relying on
searches for specific signatures in sequences of open
reading frames. For example, the initial analysis of the
genomic sequence of the TIGR4 strain [28] identified 70
genes encoding for proteins predicted to be exposed at
the surface of the pneumococcus, using one of the 3
attachment modes. This protein set included 19 pre-
dicted proteins with the peptidoglycan anchor LPXTG-
like motif, 15 predicted Cbps, 36 proteins with putative
lipid-attachment motifs (predicted lipoproteins) [28]. In
the R6 strain, a comparable set of proteins display bacte-
rial surface motifs even though not in the same number:
13 LPXTG proteins linked to the peptidoglycan, 10 Cbps
and 109 lipoproteins (this number is different than in the
TIGR4 strain probably because the authors used different
algorithms to predict the lipoproteins). The authors men-
tioned that overall 471 proteins contain a predicted signal
peptide sequence, an indication of their bacterial surface
location, either through membrane anchoring or by
secretion in the extracellular space and bound somehow
to the cell wall [29].
To date, pneumococcal surface proteins acting as viru-
lence factors and playing a role in colonization and dis-
ease are overall about 15 (mainly the ones described
p r e v i o u s l y  i n  t h i s  t e x t ) .  T a k i n g  i n t o  a c c o u n t  t h e  l a r g e
number of predicted surface-exposed, and the lack of
knowledge on key aspects of the physiopathology of the
pneumococcus, we assume that understanding of pneu-
mococcal disease might greatly profit from the study of
yet unstudied surface-exposed proteins. In order to iden-
tify new host-pneumococcal interactions that may play
roles in colonization and disease progress, we have
designed a global screening strategy. We first evaluated
the ability of the pneumococcus to adhere to host compo-Frolet et al. BMC Microbiology 2010, 10:190
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nents. Then we cloned and expressed pneumococcal pro-
teins from the Cbps and the LPXTG protein families to
systematically test the interactions of these proteins
against host proteins. We thus obtained a map of pneu-
mococcal surface proteins interactions with twelve mam-
malian proteins putatively encountered during the
colonization and/or invasion stages. This work allowed
the identification of new protein-protein interactions
between Cbp, LPXTG proteins and host proteins, and
gives renewed view of the respective roles of Cbp and
LPXTG proteins, opening the route for in depth study of
the interactions uncovered.
Results
Binding of pneumococcal strains R6 and TIGR4 to host 
proteins
We first investigated the ability of pneumococcal strains
to interact with a wide range of host proteins likely
encountered by bacterial pathogens [30]: extracellular
matrix proteins (collagens, elastin, fibronectin, laminin,
mucin), circulating plasma proteins acting in the coagula-
tion cascade (fibrinogen, plasminogen) and proteins
involved in the innate immune defense (lactoferrin, CRP,
SAP, factor H). Binding of the R6 strain to these host pro-
teins was tested in a solid-phase assay. Host proteins or
Bovine Serum Albumine (BSA) as a negative control were
coated on a multi-well plate. FITC-labeled pneumococ-
cus was added and FITC signal was measured after wash-
ings of the plate to compare binding of the
pneumococcus to BSA and host components (Fig. 1a).
The threshold for considering a positive interaction was
twice the BSA negative control. Consequently, no signifi-
cant binding of R6 bacteria was detected to collagen type
IV, to a mix of different collagens or to elastin. A low
binding level (two to three times above the BSA binding
level) was observed for CRP, fibrinogen, fibronectin,
mucin and SAP while a higher level of binding was
detected to laminin, lactoferrin, plasminogen and factor
H (Fig. 1a). A similar experiment has been performed
with the encapsulated TIGR4 strain (Fig 1b). No, or very
low binding level, was observed for the TIGR4 strain to
the collagen type IV, fibronectin, mucin and SAP and a
slight higher interaction with CRP, fibrinogen, laminin,
collagens and elastin. A high binding level of the TIGR4
strain was measured to lactoferrin, plasminogen and fac-
tor H (Fig 1b). Both R6 and TIGR4 strains bind strongly
to the lactoferrin and factor H, while the high binding
level of R6 to laminin and plasminogen is less important
in the case of the TIGR4 strain, the latter harbors a higher
recognition property to the elastin compared to the R6
strain.
Interaction of pneumococcal cells with laminin [31],
CRP [32], fibronectin [33] and mucin [34] have been
described in the literature. All other identified interac-
tions are not described to date, and to investigate these
i n t e r a c t i o n s  a t  t h e  m o l e c u l a r  l e v e l ,  w e  d e s i g n e d  a n
a p p r o a c h  t o  s y s t e m a t i c a l l y  t e s t  i n t e r a c t i o n s  b e t w e e n
selected pneumococcal surface proteins and host pro-
teins.
Identification, expression and purification of choline-
binding proteins (Cbps)
We built a list of the Cbps present in the R6 and TIGR4
genomes using the published data [28,29]. From these
sequences, 10 genes encoding Cbps were predicted in the
R6 genome, and 15 in the TIGR4 genome (Fig 2). We sys-
tematically compared the TIGR4 and R6 protein data-
bases derived from their complete genome sequence in
order to get a list of orthologs between the two organ-
isms. This work was facilitated by the high level of con-
servation of gene organization between both genomes.
This analysis led to the identification of two new Cbps in
the R6 genome not identified in the initial study [29],
namely spr0583 and spr1274 (Fig 2). In order to homoge-
nize the nomenclature, we named these newly identified
choline-binding proteins CbpL (encoded by spr0583 and
SP0667 in the R6 and TIGR4 strains, respectively) and
CbpM (encoded by spr1274 in R6, the TIGR4 SP1417
locus being a pseudo-gene). The CbpG [35] (SP0390)
ortholog in the R6 strain is split in two proteins: spr0349
contains a peptidase domain and spr0350 is a very small
protein (42 aa) with a single predicted choline-binding
domain. Thus, CbpG does not seem to exist in the R6
strain as a Cbp. T aking all these data together , we con-
clude that the R6 and TIGR4 genomes encode for 12 and
14 Cbps respectively. Figure 2 gives a comprehensive
overview of the Cbps in Streptococcus pneumoniae
strains R6 and TIGR4. This classification points out that
names previously used to identify the Cbps were confus-
ing. For instance, the ortholog of PcpC in TIGR4
(SP0377) is named CbpF in R6 (spr0337) and the ortholog
of CbpF in TIGR4 (SP0391) is PcpC in R6 (spr0351). As
CbpF was studied in R6 [36] under that name, we chose
to rename SP0391 and spr0351 CbpK. PcpA was also
renamed CbpN. We didn't rename well studied Cbps such
as PspA, LytA, LytB and LytC. A similar analysis has been
performed with the strains G54 (serotype 19F) and Hun-
gary 19A-6 (serotype 19A) (Table S1). The G54 strain
contains 14 Cbps among which only the CbpJ is absent,
while 12 Cbps have been identified in the Hungary 19A-6
strain which does not express CbpI, CbpJ and CbpG.
The level of sequence identity between the R6 and
TIGR4 Cbps orthologs was determined by Kalign http://
msa.sbc.su.se/cgi-bin/msa.cgi and ranged between 84%
and 99%, except for PspA with 63% of sequence identity.
Some of the Cbps present slight differences in their gen-
eral topology: TIGR4 CbpK is larger than R6's and has 3
more choline-binding domains. TIGR4 CbpN is reducedFrolet et al. BMC Microbiology 2010, 10:190
http://www.biomedcentral.com/1471-2180/10/190
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Figure 1 Streptococcus pneumoniae interaction with mammalian proteins. FITC labeled bacteria from the R6 and TIGR4 strains were tested for 
their interaction with several components of the host, extracellular matrix component, circulating proteins or immunity related proteins. BSA is used 
as a negative control. One representative experiment is presented in each case. (a) R6 binding pattern. Error bars correspond to the standard deviation 
of quadruplicates within each sample. (b) Comparison of TIGR4 and R6 and binding pattern. The relative values (residual BSA blank subtracted) are 
presented for comprehensive comparison of the binding patterns.Frolet et al. BMC Microbiology 2010, 10:190
http://www.biomedcentral.com/1471-2180/10/190
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by 3 choline-binding domains. Both CbpA have roughly
the same size, but 2 more choline-binding domains are
predicted in the R6 protein.
Cbps can be separated into three classes: some of them
have no predicted domain except the choline-binding
domain, as CbpI, PspA, CbpF, CbpJ, CbpK, CbpM (which
is the shortest with 129 aa), and CbpN (which is the lon-
gest with 690 aa and 10 choline-binding domains). Other
Cbps present additional domains with identified enzy-
matic functions (CbpG, CbpE, Lyt proteins). Finally some
Cbps exhibit additional predicted domains of unknown
functions (CbpL, CbpA, CbpD). All the genes encoding
the Cbps were cloned, excluding genes coding for the Lyt
proteins as their roles are well documented. CbpE was
already cloned in the laboratory [25]. PspA, CbpN and
CbpD were not expressed. CbpG and CbpK were
expressed as an insoluble form: these proteins were not
studied further. CbpA, CbpE, CbpF, CbpI, CbpJ, CbpL
and CbpM were successfully purified.
Expression and purification of LPXTG proteins
A comparable analysis has been conducted with the
LPXTG proteins (Fig 3). There are genes for 19 and 13
LPXTG family members identified in the TIGR4 and R6
Figure 2 Streptococcus pneumoniae Choline-binding proteins. Topology of the Cbps was analyzed on R6 proteins when existing otherwise TIGR4 
by SMART search of PFAM domains http://smart.embl-heidelberg.de/. Resulting general topology of the protein is figured, domains are named with 
PFAM nomenclature. YSIRK stands for the Gram-positive signal peptide (Pfam entry: PF04650). * refers to proteins for which the number of choline-
binding repeats has been determined by crystallography, and was thus used in the table [36,45-47]. The cloned part of the protein is included in the 
grey box. Protein and locus nomenclature together with the common names of the proteins, and references for their original discovery are listed in 
the second column. The third column figures the construct boundaries, and size of the complete protein, NC: Not Cloned. The latter columns display 
the positive or negative results of expression and solubility of the corresponding proteins.
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genomes, respectively [28,29]. Ten LPXTG proteins are
common to the R6 and TIGR4 genomes meaning that
some of these surface-exposed proteins are specific to
either R6 or TIGR4 strains. Five LPXTG proteins are spe-
cific of TIGR4, among which the pilin proteins encoded
at loci SP0462, SP0463 and SP0464 and thought to be
covalently associated to each other via their LPXTG-like
motif by specific pilus-sortase enzymes [37]. Because
these particular LPXTG proteins are not linked to the
peptidoglycan by the housekeeping sortase A, they have
not been included in this study. Two other LPXTG pro-
teins are present in the TIGR4 strain and absent from the
R6 strain: the metalloprotease ZmpC and PsrP, a very
large protein (4776 aa) essentially composed of a serine
rich region [38]. Three new R6 orthologs were identified:
proteins EndoD (SP0498 = spr0440), ZmpB (SP0664 =
spr0581) and ZmpA (SP1154 = spr1042) (Fig 3). NanA
(spr1536) and PclA (= spr1403) are present in the R6
strain but not in TIGR4. Among the LPXTG proteins,
spr0400 does not have a LPXTG motif, as was initially
reported [29] nor a Gram-positive anchor, was thus
excluded from our study. CbpA (SP2190) is identified
both as Cbp and LPXTG protein in the TIGR4 annota-
tions. As we did not find a LPXTG motif in SP2190, it was
excluded from the LPXTG proteins list and kept with the
Cbps (Fig 2 &3). The initial inaccurate annotation as an
LPXTG protein likely originates from the presence of an
allelic variant of CbpA harboring an LPXTG motif in
some pneumococcal strains [15,39]. Finally, the R6 strain
has 15 genes encoding for LPXTG proteins compared to
18 for the TIGR4 strain. Protein sizes range from 202 aa
(MucB) to 4776 aa (PsrP). Some of them are enzymes (Fig
3) while others may be involved in molecular recognition
(SpuA and SpnHL harbor carbohydrate binding mod-
ules...). The sequence identity between LPXTG orthologs
found in R6 and TIGR4 strains ranged between 89% and
Figure 3 Streptococcus pneumoniae LPXTG proteins. Topology of the LPXTG proteins was analyzed on R6 proteins when existing otherwise TIGR4 
by SMART search of PFAM domains http://smart.embl-heidelberg.de/. Resulting general topology of the protein is figured, domains are named with 
PFAM nomenclature. YSIRK stands for the Gram-positive signal peptide (Pfam entry: PF04650). The cloned part of the protein is included in the grey 
box. The second column gives the protein and locus nomenclature together with the common names of the proteins, and references for their original 
discovery. The third column figures the construct boundaries, and size of the complete protein, NC: Not Cloned. The latter columns bring out that 
every cloned genes gave soluble proteins produced.
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100%, except for the ZmpB protein which sequence iden-
tity is 52%. Most of the LPXTG proteins have a compara-
ble domain organization in both strains. A similar
analysis has been performed with the strains G54 and
Hungary 19A-6 (Table S2). The G54 and Hungary 19A-6
strains encode for 15 and 18 LPXTG proteins, respec-
tively. The pilus operon is missing in the G54 strain as
well as the PclA and PsrP sequences, neither the genes
encoding for ZmpC nor PclA are present in the Hungary
19A-6 strain.
As LPXTG proteins are often large, selected domains
were cloned for protein expression for most of them (Fig
3). All cloning were successful except for PclA. All the
constructs were positively tested for protein expression
and led to the production of soluble recombinant forms.
Protein interactions screening by solid-phase assay
In order to study on a large scale the interactions of the
pneumococcal choline-binding proteins and LPXTG pro-
teins with host components, a solid-phase test to screen
for interactions between the purified His-tagged pneu-
mococcal proteins and host components was designed
and automated. Chosen mammalian proteins, already
tested with pneumococci (Fig. 1), were either part of the
extracellular matrix (collagens, fibronectin, laminin,
mucin, elastin) or circulating proteins (CRP, lactoferrin,
fibrinogen, plasminogen, factor H, SAP). These proteins
were coated on a 96 wells plate and the interaction with
the purified recombinant His-tagged pneumococcal pro-
teins was detected using an anti His-Tag antibody cou-
pled to the HRP enzyme and revealed by
chemiluminescence. Each interaction experiment was
conducted at least three times using two or more differ-
ent protein preparations. Interactions observed in a
majority of at least three independent experiments are
considered as positives (Table 1).
Interaction profile of the choline-binding proteins
Elastin is the extracellular matrix component showing the
largest number of interactions with Cbps: CbpI, CbpL
and CbpF, while collagens interact only with CbpL and
laminin only with CbpE (Table 1). The most frequent
interactions have been observed with circulating pro-
teins, such as CRP, factor H and plasminogen. Four differ-
ent Cbps interact with CRP: CbpI, CbpM, CbpJ and
CbpL. CbpE and CbpA, interact with factor H, the latter
interaction confirming previous results [40], Plasmino-
gen interacts with CbpE and CbpF (Table 1). Interactions
between CbpE and laminin or plasminogen confirm our
previous observations to which we add factor H herein
[25].
Interaction profile of the LPXTG proteins
Even though all expressed LPXTG proteins were pro-
duced as soluble recombinant proteins, some of them
gave poor purification yield or poor signal detection dur-
ing the screen. These restrictions led to the abandon in
the screen assay of PavB, ZmpA, MucB and PsrP. The
most common interactions encountered with the LPXTG
candidates involved the collagen IV (PrtA, ZmpB, NanA
and spr1806) and the plasminogen (SpuA, Eng, PrtA and
spr1806) (Table 1). NanA also interacts with collagens
and fibrinogen (Table 1). The interaction level of NanA
with lactoferrin was not significant in our assay contrary
to a previous observation [17].
Dose-responses curves
We chose to investigate the dose-response of three
unstudied Cbps for which we observed host-protein
binding functions: the solid-phase assay screening led to
the observation that CbpL interacts with collagens, elas-
tin and CRP, CbpI binds to elastin and CRP and CbpM
binds only to CRP. In this experiment, 1 μg of each mam-
malian protein is coated and increasing amounts of pneu-
mococcal proteins is used, from 0.8 to 200 pmoles per
well. For all three analyzed Cbps, the interaction with
mammalian proteins is dose-dependent (Fig 4). The high-
e s t  l e v e l  o f  b i n d i n g  o f  C b p L  i s  o b s e r v e d  w i t h  e l a s t i n ,
intermediate response with collagens and CRP compared
with the BSA negative control (Fig 4). These data confirm
the results of the screen, and also comfort the "semi-
quantitative" informations about the level of binding that
we obtained from the screen. The interaction of CbpI
with elastin and CRP yielded the most important
response levels in the dose-response measurements, in
accordance with the screen assay but a significant level of
interaction was also observed with collagens (Fig 4). Even
though the sole interaction of CbpM which came out
from the screen procedure was with CRP, confirmed in
the dose-response analysis, this more detailed character-
ization allows to propose that CbpM interacts with elas-
tin but too weakly to be considered as positive during the
screen procedure (Fig 4). All together these results vali-
date the procedure that we used to select the interactions
that emerge from the screen.
Discussion
We have presented an experimental set up that allowed
the analysis of the binding properties of 19 surface-
exposed pneumococcal proteins, leading to the screen of
more than 200 interactions, most of which have never
been reported in the literature before. The validity of this
approach is strengthened by the fact that known interac-
tions were « rediscovered ». For example, we confirmed
the interaction between CbpA and Factor H [40]. Com-
plementary ELISA analysis gave a confirmation of the
validity of our procedure on chosen protein-protein
interactions. From this screen, we conclude that whereas
LPXTG proteins do not appear to be major adhesins,
Cbps seem to be more important players in the adhesionFrolet et al. BMC Microbiology 2010, 10:190
http://www.biomedcentral.com/1471-2180/10/190
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Table 1: Interactions between host and pneumococcal proteins
Collagens Collagen IV Fibrinogen Laminin Elastin CRP Factor H Plasminogen Fibronectin Mucin 
Lactoferrin
CbpA +
CbpI ++
CbpM +
CbpJ +
CbpL ++ +
CbpF ++
CbpE ++ + +
StrH
ZmpC
SpuA +
SpnHL
Eng +
EndoD
PrtA ++
BgaA
ZmpB +
NanA ++ +
PfbA
spr1806 +
This table summarizes the ELISA interaction experiments. Each positive interaction was validated in a majority of at least 3 independent 
experiments (see material and methods) and is represented by a cross. Empty boxes stand for an absence of detected interaction. Pneumococcal 
proteins are figured on the left and the tested mammalian proteins are at the top of the table, those giving no interaction have been grouped at 
the right of the table.Frolet et al. BMC Microbiology 2010, 10:190
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processes. One explanation can be that most of the Cbps
are not associated with enzymatic functions (except the
Lyt proteins, CbpD, CbpE and CbpG, see Fig 2). Probably
the main function of the Cbps (except for the Lyt pro-
teins) resides in the host-pathogen interaction, and adhe-
sion processes. Most of the LPXTG proteins do exhibit
complex 'multi'-functions (enzymatic domains plus dif-
ferent binding domains, see Fig 3), rendering plausible
the hypothesis that they have more diverse functions at
the surface of the bacteria. Indeed, the results obtained
tend to minimize their roles in the adhesion processes.
However one has to keep in mind that often only part of
the LPXTG proteins was tested as they are usually larger
proteins than the Cbps. It's possible that this bias led us to
miss significant interactions. Another point is that only
protein-protein interactions were tested during the
course of the screen. Yet carbohydrates are important
components of the host, they were not included in that
study and could be an important target of the LPXTG
proteins, in particular for the ones that bear carbohy-
drate-binding modules as it was recently proven for SpuA
[41]. Finally, this screen addressed a small fraction of host
factors potentially involved in the interactions with the
pneumococcus. Thus our screen gives an overview of
some protein-protein interactions and extension on this
work would require higher throughput techniques such
as those based on chips. It's interesting to note that some
of the LPXTG found to be adhesins during the course of
this screen are proteases such as PrtA and ZmpB. One
tempting hypothesis that has already been proposed for
PrtA [42] could be that these proteins are involved in the
cleavage of host proteins in order to penetrate into the
tissues or escape the immune system. Future research will
have to elucidate these questions and in particular, the
fate of the mammalian proteins after the interactions.
During the course of the screen, we identified 3 Cbps,
CbpI, CbpL and CbpM that interact with elastin. To the
best of our knowledge, this is the first time that interac-
tions of pneumococcal proteins with elastin are discov-
ered. Elastin is a major component of the lungs and blood
vessels, and is thus probably frequently encountered by
the bacteria. CbpI and CbpL are only expressed in the
TIGR4 strain and harbor a high level binding to elastin,
while CbpM is specific of the R6 strain and binds weakly
Figure 4 Dose dependent binding of chosen Cbps to CRP, elastin and collagens. Increasing concentrations of His-Tagged Cbps (from 0,8 to 200 
pmole) have been bound to 1 μg of BSA as a control, CRP, collagens and elastin. The quantity of bound protein is detected in a luminometer using 
an HRP conjugated antibody directed against the His-Tag.Frolet et al. BMC Microbiology 2010, 10:190
http://www.biomedcentral.com/1471-2180/10/190
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to elastin. These data are in accordance with the bacterial
binding pattern to elastin: no interaction of the R6 strain
was observed with elastin while the TIGR4 strain pres-
ents a significant binding property to elastin, indicating
that in this latter strain, and despite the presence of the
capsule, the recognition to elastin might be due to CbpI
and CbpL (Fig. 1). These newly characterized interactions
open the way to a better understanding of the contribu-
tion of choline-binding proteins during the invasion pro-
cess. Considering the general interest in the identification
and validation of new protein vaccine candidates, that
would elicit protection against a broader range of pneu-
mococcal strains and/or play a significant role in the viru-
lence process, it is interesting to note that all the
identified recombinant proteins that positively interact
with the host proteins are also present in the G54 and
Hungary 19A-6 strains, except CbpJ in both strains and
CbpI in the latter strain.
We also observed an interaction between some Cbps
and the CRP. The interaction between Streptococcus
pneumoniae and CRP is one of the first identified host-
pathogen interaction at the molecular level [32]. CRP
stands for C Reactive Protein, with C standing for C poly-
saccharide, which contains the teichoic and lipoteichoic
acids from pneumococcus. In fact, CRP is interacting
with phosphocholines (PCho) [43] harbored by teichoic
and lipoteichoic acids. The possibility exists that Cbps
could harbor in their choline-binding domains enough
PCho to reproduce this interaction. However, it's impor-
tant to note that not every purified Cbp did interact with
CRP , leaving opened the question of a direct interaction
between Cbps and CRP.
Conclusions
We have presented an experimental design that allowed
the analysis of the binding properties of 19 surface-
exposed pneumococcal proteins, leading to the discovery
of 20 new interactions with host proteins. This screen
opens the route for in depth study of the role of these sur-
face exposed proteins in the virulence processes,
Methods
Cloning of the cbp and lpxtg genes
Oligonucleotides were designed to amplify the required
fragments either on R6 or TIGR4 genomic DNA (ATCC
BAA334D). R6 genes were preferentially cloned when
existing. In order to maximize chances to get soluble pro-
teins expressed in E. coli cytoplasm, we systematically
eliminated the predicted signal peptides, transmembrane
domains or Gram-positive anchor when present, as for
CbpA (Fig 2). The Ligation Independent Cloning (LIC)
technique was chosen in order to facilitate high through-
put cloning steps [44]); LIC extensions were in conse-
quence included in the primers. PCR amplification was
performed using the Phusion polymerase (Finnzyme,
#F530L). The amplified gene fragments were cloned into
pLIM01 or pLIM12 LIC-vectors (PX'Therapeutics,
Grenoble) leading to N-terminal His-Tag fusion proteins.
Plasmids were transformed into E. coli DH5a and inserts
were sequenced to verify the absence of undesired muta-
tions (Cogenics, Grenoble). The E. coli strain
BL21CodonPlus®(DE3)RIL (Stratagene #230245) was
used for protein expression.
Protein expression and purification
Transformed bacteria were precultured (3 mL) in Terrific
Broth (TB) with the appropriate antibiotic, chloramphen-
icol 34 μg/mL, ampicillin 100 μg/mL (pLIM01 vector) or
kanamycin 50 μg/mL (pLIM12 vector) at 37°C for over-
night incubation. A volume of 250 mL of TB media (plus
ampicillin or kanamycin only) was inoculated with the
overnight culture and the bacterial growth was per-
formed at 37°C until an OD at 600 nm of 2 was reached.
The protein expression was induced by 1 mM IPTG and
the culture incubation was carried on at 15°C for about 18
hours.
Bacterial culture was spun down and the pellet resus-
pended in an appropriate buffer composed of 50 mM
Hepes pH7.0 or 50 mM Tris pH8.0 (depending on the pI
of the expressed protein), 150 mM NaCl, 40 mM Imida-
zole and a cocktail of protease inhibitors (complete EDTA
free, Roche). After cell lysis by sonication, the recombi-
nant proteins were recovered from the soluble fraction
and loaded onto a 1 ml - prepacked HisTrap™ HP (17-
5247-01, GE Healthcare) column or HIS-Select®  High
Flow Cartridge (Sigma #H7788). Column equilibration
was performed in the same buffer as lysis. After extensive
washing, recombinant proteins were eluted with a 20 -
500 mM imidazole gradient. The eluted fractions were
analyzed on an SDS acrylamide denaturing gel. If neces-
sary (generally when the purity of the protein appeared to
be less than 90% on the gel), the purification process was
continued with an ion exchange column and/or a size
exclusion chromatography. Protein concentrations were
determined from the absorbance at 280 nm with a spec-
trophotometer (Nanovue, GE healthcare). For the cho-
line-binding proteins, yields ranged between 5 mg/liter
(CbpF) and 120 mg/liter (CbpM, CbpJ) of E. coli culture
with a purity estimated on SDS-PAGE greater than 90%.
Cbps are often more stable when stored in the elution
buffer of the affinity column than in PBS. The purifica-
tion yields of LPXTG proteins ranged between less than 1
mg to 60 mg/liter of E. coli culture, with a purity level
estimated on SDS-PAGE of a minimum of 75%.
S. pneumoniae interactions screening by solid-phase assay
Black 96 well plates (Greiner 655077) were coated over-
night at 4°C with 1 μg (in 100 μL PBS pH7.0) of the fol-Frolet et al. BMC Microbiology 2010, 10:190
http://www.biomedcentral.com/1471-2180/10/190
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lowing mammalian proteins: collagen IV (Sigma, C5533),
collagens (Merck, 234112), elastin (Merck, 324751),
fibronectin (Merck, 341635), laminin (Sigma, L2020),
fibrinogen (Sigma, F3879), mucin (Sigma, M3895), plas-
minogen (Sigma, P7999), lactoferrin (Sigma, L3770), C-
reactive protein (Merck, 236608), serum amyloïd P com-
ponent (SAP, Merck, 565190), factor H (Merck, 341274),
and bovine serum albumin (BSA, Promega R3961) as a
control. The plate is saturated the day after at room tem-
perature for 1 h with 1% BSA (Sigma, A7030).
Streptococcus pneumoniae from the R6 strain was cul-
tured in T odd Hewitt broth (BD) to an OD of 0.3, har-
v e s t e d  a n d  w a s h e d  i n  P B S .  O n e  m g  o f  F I T C  ( S i g m a ,
F7250) was diluted in 1 mL of PBS, centrifuged and the
supernatant was used to resuspend the R6 pellet. The
bacteria were kept 20 minutes in the dark. Afterwards,
several centrifugation steps (usually 5 or 6, 4000 g-2 min)
are conducted in PBS in order to remove free FITC.
FITC-labelled bacteria (108 cfu) were then deposited in
each well (in 50 μL of PBS, BSA 0,2%). The bacteria were
left to interact for 2 h at 37°C, before washing eight times
with 100 μL of PBS. The fluorescence signal was read in a
fluorimeter (FLUOstar Optima, BMG Labtech).
Protein interactions screening by solid-phase assay
White 96 well plates (Greiner 655074) were coated over-
night at 4°C with 1 μg (in 100 μL PBS pH7.0) of the same
mammalian proteins as in the previously described
experiment: collagen IV, collagens, elastin, fibronectin,
laminin, fibrinogen, mucin, plasminogen, lactoferrin,
CRP, SAP, factor H, and BSA as a control. The following
steps were conducted at room temperature in a Micro-
star® lab robot (Hamilton). Saturation was performed for
1 h with 200 μL of PBS 2% BSA (Sigma, A7030). His-
Tagged recombinant pneumococcal surface protein (200
pmole in 100 μL PBS) were added to each well and left for
two hours, three washing steps of ten minutes in 200 μL
PBS, Tween 0,03% were then performed. The anti His-
HRP-coupled antibody (Sigma, A7058) was diluted
1000× in PBS Tween 0,03% BSA 0,2% and 100 μL were
added to the wells. Three washings in 200 μL PBS, Tween
0,03%, followed this last step. The antibody signal was
revealed with 100 μL of ECL (Pierce, 32106) and the lumi-
nescence immediately read in a FLUOstar OPTIMA
(BMG Labtech). Each well was triplicated. The threshold
for considering a positive interaction was twice the BSA
negative control.
In order to get the maximal accuracy in the interpreta-
tion of the results, we built a specific protocol for a global
analysis of the results and retained as positive the interac-
tions observed in the majority of data set, provided from
at least 3 independent experiments.
Dose response curves
Similar protocol was used except that increasing quanti-
ties of pneumococcal His-tagged proteins were used in
the interaction steps, from 0.8 to 200 pmoles. Dose-
response curves are in consequence presented with a log-
arithmic scale.
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